These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
46. A comparison of amitriptyline and a fluphenazine/nortriptyline preparation in anxiety-depressive states. Bennie EH; Schiff AA Scott Med J; 1976 Oct; 21(4):204-9. PubMed ID: 793005 [TBL] [Abstract][Full Text] [Related]
47. Sampling time, dosage schedule, and nortriptyline plasma levels. Ziegler VE; Knesevich JW; Wylie LT; Biggs JT Arch Gen Psychiatry; 1977 May; 34(5):613-5. PubMed ID: 871235 [TBL] [Abstract][Full Text] [Related]
48. Acute open-trial nortriptyline therapy of bereavement-related depression in late life. Pasternak RE; Reynolds CF; Schlernitzauer M; Hoch CC; Buysse DJ; Houck PR; Perel JM J Clin Psychiatry; 1991 Jul; 52(7):307-10. PubMed ID: 2071562 [TBL] [Abstract][Full Text] [Related]
49. Nortriptyline and pituitary-thyroid function in affective disorder. Nordgren L; von Schéele C Pharmacopsychiatria; 1981 Mar; 14(2):61-5. PubMed ID: 6785769 [TBL] [Abstract][Full Text] [Related]
50. Anxiety/depression in elderly patients. A double-blind comparative study of fluphenazine/nortriptyline and promazine. Brodie NH; McGhie RL; O'Hara H; Valle-Jones JC; Schiff AA Practitioner; 1975 Nov; 215(1289):660-4. PubMed ID: 1105543 [TBL] [Abstract][Full Text] [Related]
51. The relationship between nortriptyline plasms levels and clinical effects. Kragh-Sorensen P Proc R Soc Med; 1975 Feb; 68(2):99-102. PubMed ID: 1101270 [No Abstract] [Full Text] [Related]
52. Treatment of depressed tinnitus patients with nortriptyline. Sullivan MD; Dobie RA; Sakai CS; Katon WJ Ann Otol Rhinol Laryngol; 1989 Nov; 98(11):867-72. PubMed ID: 2817678 [TBL] [Abstract][Full Text] [Related]
53. A sequential trial comparing two plasma levels of nortriptyline. Burrows G; Turecek LR; Davies B; Mowbray R; Scoggins BA Aust N Z J Psychiatry; 1974 Mar; 8(1):21-3. PubMed ID: 4606144 [No Abstract] [Full Text] [Related]
54. A pharmacokinetic approach to the treatment of depression. Sjöqvist F Int Pharmacopsychiatry; 1971; 6(3):147-69. PubMed ID: 4950568 [No Abstract] [Full Text] [Related]
55. [Evaluation of the therapeutic action of nortriptyline in depressive syndromes]. Soulairac A; de Mijolla A; Berouti R; Baron JB; Aymard N; Mohr W Ann Med Psychol (Paris); 1967 Dec; 2(5):772-5. PubMed ID: 5585707 [No Abstract] [Full Text] [Related]
56. [A double-blind nomifensine-nortriptyline trial in ambulatory patients conducted by psychiatrists in private practice: results and comments]. Coudray JP; Dufour H; Garello JL; Mollo Y; Pascal F; Poisson D; Scotto JC; Simart G; Sormani J; Tourame G Nouv Presse Med; 1978 Jun; 7(26):2333-8. PubMed ID: 353721 [TBL] [Abstract][Full Text] [Related]
57. Correlation of subjective side effects with plasma concentrations of nortriptyline. Asberg M; Cronholm B; Sjöqvist F; Tuck D Br Med J; 1970 Oct; 4(5726):18-21. PubMed ID: 5470429 [TBL] [Abstract][Full Text] [Related]
58. A randomized trial of nortriptyline combined with transdermal nicotine for smoking cessation. Prochazka AV; Kick S; Steinbrunn C; Miyoshi T; Fryer GE Arch Intern Med; 2004 Nov; 164(20):2229-33. PubMed ID: 15534159 [TBL] [Abstract][Full Text] [Related]
59. [Place of nortriptyline in the group of antidepressants; clinical and electroencephalographic considerations]. Ropert R; Bergès J Ann Med Psychol (Paris); 1967 May; 125(5):750-5. PubMed ID: 6064543 [No Abstract] [Full Text] [Related]
60. Ophthalmological effects of nortriptyline--relationship to plasma level. Asberg M; Germanis M Pharmacology; 1972; 7(5):349-56. PubMed ID: 4566251 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]